CXCL12 and neoplasm: iCAFs contribute to immune evasion by releasing pro-inflammatory cytokines and directly influencing pancreatic cancer cells to facilitate tumor progression; their secretion of CXCL12 may also support TLS formation by lymphocyte recruitment [53].